tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Xenon (XENE)
NASDAQ:XENE
US Market
XENE
Xenon
RESEARCH TOOLSreports

Xenon (XENE) Stock News & Sentiment

Compare
424 Followers
Xenon Pharmaceuticals: Undervalued ‘Pipeline-in-a-Drug’ Story with Blockbuster Potential Ahead of Key 2026 Readouts
Premium
Ratings
Xenon Pharmaceuticals: Undervalued ‘Pipeline-in-a-Drug’ Story with Blockbuster Potential Ahead of Key 2026 Readouts
3d ago
XENE
Xenon Pharmaceuticals: Advancing Late-Stage Epilepsy and Depression Programs and Expanding NaV1.7/Kv7 Pipeline Support Buy Rating and $55 Target
Premium
Ratings
Xenon Pharmaceuticals: Advancing Late-Stage Epilepsy and Depression Programs and Expanding NaV1.7/Kv7 Pipeline Support Buy Rating and $55 Target
4d ago
XENE
Xenon Sets 2026–2027 Milestone Timetable for Azetukalner and Pain Pipeline
Premium
Company Announcements
Xenon Sets 2026–2027 Milestone Timetable for Azetukalner and Pain Pipeline
4d ago
XENE
Xenon to Showcase Neuroscience Pipeline at J.P. Morgan Healthcare Conference
Premium
Company Announcements
Xenon to Showcase Neuroscience Pipeline at J.P. Morgan Healthcare Conference
11d ago
XENE
Xenon Pharmaceuticals: Strategic Advancements and Promising Clinical Results Justify Buy Rating
Premium
Ratings
Xenon Pharmaceuticals: Strategic Advancements and Promising Clinical Results Justify Buy Rating
1M ago
XENE
Xenon’s Promising Epilepsy Treatment and Strategic Growth Potential Drive Buy Rating
Premium
Ratings
Xenon’s Promising Epilepsy Treatment and Strategic Growth Potential Drive Buy Rating
1M ago
XENE
Xenon Pharmaceuticals Unveils Promising Long-Term Epilepsy Treatment Data
Premium
Company Announcements
Xenon Pharmaceuticals Unveils Promising Long-Term Epilepsy Treatment Data
1M ago
XENE
More XENE News >

XENE News on the Web

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Xenon (XENE)
TipRanks News
Neutral
Cantor Fitzgerald Sticks to Its Buy Rating for Xenon (XENE)
TipRanks News
Neutral
Why Xenon Pharmaceuticals Inc.’s (XENE) Stock Is Down 5.43%
AAII
Neutral
Xenon (XENE) Receives a New Rating from Chardan Capital
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and BioLife Solutions (BLFS)
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Xenon (XENE) and Biohaven Ltd. (BHVN)
TipRanks News
Neutral
Biohaven MDD failure a 'net positive' for Xenon Pharmaceuticals, says Stifel
The Fly
Neutral
William Blair views Biohaven depression miss as disappointing
The Fly
Neutral

News Score - Last 7 Days

Neutral
XENE
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is XENE’s Media Buzz Sentiment?
1 articles about XENE were published this week. In an average week, 2.5 articles are published.
    What is XENE’s weekly average amount of articles?
    In an average week, 2.5 articles about XENE are published.
      What is XENE’s News Sentiment?
      50% of articles about XENE were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        KRYSKrystal Biotech
        EHABEnhabit, Inc
        WSTWest Pharmaceutical Services
        SEMHFSiemens Healthineers AG
        RPRXRoyalty Pharma
        Showing the stocks with the most bullish news sentiment over the past week